Opzelura Will Be a New Cream for Eczema

Opzelura (ruxolitinib) 1.5% cream will be a new Rx for eczema.

It's the first TOPICAL "Janus kinase (JAK) inhibitor" to treat eczema (atopic dermatitis), an itchy inflammation of the skin.

Expect Opzelura to be saved as a last resort for patients 12 and older...after topical steroids (hydrocortisone, etc) or other topicals for eczema (ElidelProtopic, etc).

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote